|
SWITZERLAND
Basel
 We
are a leader in the emerging field of proteomics, the comprehensive
study of proteins. We have successfully integrated proteomics with
genomics to create an innovative, proprietary drug discovery platform
that allows the systematic separation, identification and characterisation
of proteins on an industrial scale. Our goal is to use that platform
to enable the development of a new generation of break-through products
by: building a pipeline of proprietary small molecule and antibody
drug and diagnostic products based on a portfolio of patent applications
relating to, or to the use of, disease-associated proteins; and
providing proteomics services and data to the pharmaceutical and
life sciences industries.
|
|
Basel
 Proteome,
Inc. and DoubleTwist, Inc. today announced a partnership to provide
data from Proteome's BioKnowledge Library through the genomic research
portal DoubleTwist.com. Proteome's BioKnowledge Library provides
extensive biological knowledge of genes and proteins across a wide
variety of species.
|
 GeneData
is a global leader in the development of bioinformatics systems and
related services in the functional genomics arena. We deliver innovative
computational solutions for the management and intelligent analysis
of large quantities of structurally complex biological data, generated
by genome sequencing, microarrays, protein expression profiling, metabolic
profiling and high-throughput screening. Our partners include major
life-sciences organizations and some of the world's most prestigious
research institutions. We strive to help our partners maximize their
return on investment from costly technologies and gain a deeper understanding
of underlying biological processes for advancement of their own research
and product development. Founded in 1997, GeneData has grown to a
team of around 70 experts from diverse fields including molecular
biology, biochemistry, computer science, (bio)physics, mathematics
and statistics. Our growth continues as we recruit the best people
for developing and applying in-silico methods for functional genomics
problems. |
|
Geneva
 EUROPROTEOME
applies state-of-the-art, convergent gene expression technologies
- in particular proteomics and transcriptomics to human epithelial
cancers (e.g. colon or lung cancer) in order to identify cancer-specific
protein expression patterns (targets / markers) suited for clinical
applications. After characterizing and validating these identified
targets, EUROPROTEOME offers these targets for co-development agreements
with industrial clients and marketing partners.
|
GeneBio is committed to providing quality databases, software tools
and services to the Life Science industry particularly in the field
of proteomics. We are the exclusive worldwide representative for the
licensing to commercial institutions of the proteomics databases and
software tools which are developed and maintained by the Swiss Institute
of Bioinformatics (SIB). |
 GeneProt's
goal is to become the leader in the discovery, identification and
characterization of proteins and their functions for major disabling
or life threatening diseases. GeneProt has successfully combined the
elements of science, technology and management to ensure its success.
GeneProt's team of cutting-edge scientists, those behind many of the
breakthroughs that define the current state of proteomic knowledge,
is supported by state-of-the art equipment, including one of the industrial
world's most powerful computer systems, management expertise in the
biotech field and a number of strategic partnerships. |
| AUSTRIA |
|
|
|
